Janus Henderson Group plc 13D and 13G filings for Soleno Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-08-14 11:16 am Purchase | 2025-06-30 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 5,308,009 10.500% | 155,340![]() (+3.01%) | Filing |
2025-05-14 12:02 pm Sale | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 5,152,669 11.200% | -35,596![]() (-0.69%) | Filing |
2025-02-14 11:56 am Purchase | 2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 5,188,265 12.000% | 1,107,166![]() (+27.13%) | Filing |
2024-11-14 12:51 pm Sale | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 4,081,099 10.500% | -82,579![]() (-1.98%) | Filing |
2024-10-03 09:55 am Purchase | 2024-09-30 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 4,163,678 10.100% | 1,639,781![]() (+64.97%) | Filing |
2024-02-13 5:35 pm Purchase | 2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 2,523,897 8.300% | 1,064,197![]() (+72.91%) | Filing |
2023-10-06 11:45 am Purchase | 2023-09-26 | 13G | Soleno Therapeutics, Inc. SLNO | JANUS HENDERSON GROUP PLC JHG | 1,459,700 10.100% | 1,459,700![]() (New Position) | Filing |